Bio-Rad Laboratories ROE 2010-2025 | BIO

Current and historical return on equity (ROE) values for Bio-Rad Laboratories (BIO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Bio-Rad Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-2.16B $6.68B -31.46%
2024-12-31 $-1.84B $6.57B -24.68%
2024-09-30 $-0.78B $7.49B -9.71%
2024-06-30 $-1.33B $6.78B -16.07%
2024-03-31 $-0.32B $9.05B -3.72%
2023-12-31 $-0.64B $8.74B -7.20%
2023-09-30 $-0.16B $8.42B -1.75%
2023-06-30 $-0.43B $8.45B -4.72%
2023-03-31 $-0.19B $9.76B -2.08%
2022-12-31 $-3.63B $9.62B -39.03%
2022-09-30 $-6.02B $8.45B -58.38%
2022-06-30 $-1.93B $8.92B -16.03%
2022-03-31 $-0.09B $10.18B -0.71%
2021-12-31 $4.25B $13.69B 33.22%
2021-09-30 $6.67B $15.33B 56.23%
2021-06-30 $4.05B $11.60B 39.63%
2021-03-31 $4.11B $10.61B 44.78%
2020-12-31 $3.81B $9.88B 47.16%
2020-09-30 $3.52B $8.83B 49.88%
2020-06-30 $1.95B $7.35B 31.73%
2020-03-31 $1.58B $6.29B 27.87%
2019-12-31 $1.76B $5.76B 33.11%
2019-09-30 $0.38B $5.13B 7.71%
2019-06-30 $0.90B $5.49B 18.76%
2019-03-31 $0.57B $4.86B 12.44%
2018-12-31 $0.37B $4.02B 8.09%
2018-09-30 $1.28B $4.90B 30.12%
2018-06-30 $1.03B $4.64B 27.64%
2018-03-31 $0.77B $4.49B 23.46%
2017-12-31 $0.12B $2.93B 4.32%
2017-09-30 $0.02B $2.85B 0.58%
2017-06-30 $0.01B $2.81B 0.44%
2017-03-31 $0.03B $2.71B 0.94%
2016-12-31 $0.03B $2.58B 0.96%
2016-09-30 $0.09B $2.70B 3.63%
2016-06-30 $0.09B $2.62B 3.69%
2016-03-31 $0.10B $2.54B 4.19%
2015-12-31 $0.11B $2.49B 4.60%
2015-09-30 $0.10B $2.43B 4.45%
2015-06-30 $0.10B $2.36B 4.35%
2015-03-31 $0.10B $2.20B 4.59%
2014-12-31 $0.09B $2.19B 4.07%
2014-09-30 $0.08B $2.18B 3.66%
2014-06-30 $0.06B $2.25B 2.82%
2014-03-31 $0.07B $2.23B 3.02%
2013-12-31 $0.08B $2.19B 3.71%
2013-09-30 $0.09B $2.12B 4.42%
2013-06-30 $0.14B $2.07B 7.00%
2013-03-31 $0.15B $2.03B 7.86%
2012-12-31 $0.17B $2.02B 8.64%
2012-09-30 $0.18B $1.94B 9.88%
2012-06-30 $0.19B $1.85B 10.38%
2012-03-31 $0.18B $1.84B 10.11%
2011-12-31 $0.18B $1.74B 10.57%
2011-09-30 $0.19B $1.69B 11.38%
2011-06-30 $0.19B $1.73B 11.79%
2011-03-31 $0.18B $1.61B 12.51%
2010-12-31 $0.19B $1.54B 13.35%
2010-09-30 $0.16B $1.43B 11.75%
2010-06-30 $0.15B $1.30B 11.74%
2010-03-31 $0.15B $1.30B 12.16%
2009-12-31 $0.15B $1.28B 12.36%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.175B $2.567B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.407B 27.95
Boston Scientific (BSX) United States $155.727B 38.99
Stryker (SYK) United States $146.049B 30.54
EssilorLuxottica (ESLOY) France $127.608B 0.00
Medtronic (MDT) Ireland $106.425B 15.09
Haleon (HLN) United Kingdom $51.128B 29.10
Lonza Group Ag (LZAGY) Switzerland $50.009B 0.00
ResMed (RMD) United States $35.893B 26.96
GE HealthCare Technologies (GEHC) United States $32.299B 15.33
Agilent Technologies (A) United States $31.909B 20.73
Terumo (TRUMY) Japan $27.168B 35.29
Insulet (PODD) United States $22.874B 89.79
Koninklijke Philips (PHG) Netherlands $21.656B 15.57
Zimmer Biomet Holdings (ZBH) United States $18.236B 11.71
Baxter (BAX) United States $15.652B 11.69
Smith & Nephew SNATS (SNN) United Kingdom $12.683B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Lantheus Holdings (LNTH) United States $5.228B 13.19
Prestige Consumer Healthcare (PBH) United States $4.233B 18.91
Perrigo (PRGO) Ireland $3.680B 9.33
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.319B 24.48
Haemonetics (HAE) United States $3.253B 14.82
Envista Holdings (NVST) United States $3.097B 25.73
GN Store Nord (GNNDY) Denmark $2.224B 18.42
QuidelOrtho (QDEL) United States $2.074B 14.27
LeMaitre Vascular (LMAT) United States $1.857B 41.52
AtriCure (ATRC) United States $1.711B 0.00
Acuren (TIC) United States $1.276B 0.00
Neogen (NEOG) United States $1.272B 16.28
AdaptHealth (AHCO) United States $1.212B 12.30
Kestra Medical Technologies (KMTS) United States $1.156B 0.00
Green Thumb Industries (GTBIF) United States $1.109B 24.95
BioLife Solutions (BLFS) United States $1.039B 0.00
Phibro Animal Health (PAHC) United States $0.990B 12.65
InMode (INMD) Israel $0.927B 9.34
CeriBell (CBLL) United States $0.608B 0.00
Evolus (EOLS) United States $0.593B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.573B 0.00
Curaleaf Holdings (CURLF) Canada $0.550B 0.00
Valneva SE (VALN) France $0.535B 0.00
Owens & Minor (OMI) United States $0.510B 4.23
Capricor Therapeutics (CAPR) United States $0.452B 0.00
Tilray Brands (TLRY) Canada $0.428B 0.00
Surmodics (SRDX) United States $0.415B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.334B 0.00
VAREX IMAGING (VREX) United States $0.316B 11.62
Aurora Cannabis (ACB) Canada $0.298B 53.00
Cresco Labs (CRLBF) United States $0.295B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.17
Sanara MedTech (SMTI) United States $0.258B 0.00
ZimVie (ZIMV) United States $0.255B 11.57
Cerus (CERS) United States $0.243B 0.00
Canopy Growth (CGC) Canada $0.243B 0.00
Verano Holdings (VRNOF) United States $0.229B 0.00
Sanuwave Health (SNWV) United States $0.224B 0.00
OraSure Technologies (OSUR) United States $0.215B 0.00
Quanterix (QTRX) United States $0.202B 0.00
Brainsway (BWAY) Israel $0.192B 51.00
Biote (BTMD) United States $0.189B 5.32
TriSalus Life Sciences (TLSI) United States $0.189B 0.00
High Tide (HITI) Canada $0.182B 0.00
Omeros (OMER) United States $0.181B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.57
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.137B 16.92
Jin Medical (ZJYL) China $0.118B 0.00
TerrAscend (TSNDF) Canada $0.107B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.60
Agape ATP (ATPC) $0.087B 0.00
MacroGenics (MGNX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Veru (VERU) United States $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Modular Medical (MODD) United States $0.047B 0.00
United-Guardian (UG) United States $0.038B 13.17
Rockwell Medical (RMTI) United States $0.034B 0.00
Nephros (NEPH) United States $0.029B 38.86
Safety Shot (SHOT) United States $0.021B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00